Cargando…
The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders
Over the past few decades, as gene discovery methods and sequencing technologies have evolved, many genetic variations that significantly increase the risk of or cause neurodegenerative diseases have been identified. However, knowledge of those pathogenic mutations and subsequent mechanism-focused s...
Autores principales: | Shin, Jun Wan, Lee, Jong-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784517/ https://www.ncbi.nlm.nih.gov/pubmed/29399048 http://dx.doi.org/10.1177/1756285617741837 |
Ejemplares similares
-
CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023) -
CRISPR-based tools for plant genome engineering
por: Volpi e Silva, Nathalia, et al.
Publicado: (2017) -
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
por: Devi, Shweta, et al.
Publicado: (2021) -
A CRISPR method for genome engineering
por: Wilkinson, Royce, et al.
Publicado: (2014) -
CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
por: Tu, Zhuchi, et al.
Publicado: (2015)